Synergy CHC (SNYR) Stock Overview
Provides consumer health care, beauty, and lifestyle products in the United States, Canada, Mexico, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
SNYR Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Synergy CHC Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.20 |
| 52 Week High | US$4.00 |
| 52 Week Low | US$0.18 |
| Beta | 0.61 |
| 1 Month Change | 2.14% |
| 3 Month Change | -65.06% |
| 1 Year Change | -93.73% |
| 3 Year Change | 68.82% |
| 5 Year Change | -82.68% |
| Change since IPO | -99.16% |
Recent News & Updates
Recent updates
SNYR: Higher Discount Rate Will Shape Outlook Despite Nasdaq Listing Risk
Analysts have reset their price target on Synergy CHC to $3.75 from $6, reflecting a higher $12.46 discount rate, more conservative forecasts for revenue growth and profit margins, and a higher assumed future P/E of 35.70 based on recent sector research trends. Analyst Commentary Street research around the broader specialty pharma and biotech space gives some useful context for how analysts might be thinking about Synergy CHC, especially when it comes to execution risk, research outcomes, and how those factors can feed into valuation multiples and discount rates.
Cautious On Beverage Rollout And DSD Costs Yet Expecting Healthier Margins Ahead
Catalysts About Synergy CHC Synergy CHC develops and markets FOCUSfactor branded cognitive health supplements and functional beverages across retail and international channels. What are the underlying business or industry changes driving this perspective?Brain Health And Clean Energy Trends Will Support Long Term Undervaluation Thesis
Catalysts About Synergy CHC Synergy CHC develops and sells FOCUSfactor branded brain health supplements and functional beverages across retail, convenience and international channels. What are the underlying business or industry changes driving this perspective?
Rapid Retail Expansion And Direct Store Distribution Will Transform Long Term Earnings Power
Catalysts About Synergy CHC Synergy CHC develops and markets FOCUSfactor branded cognitive health supplements and functional energy and brain health beverages across retail and international channels. What are the underlying business or industry changes driving this perspective?Investors Aren't Buying Synergy CHC Corp.'s (NASDAQ:SNYR) Earnings
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...Should You Think About Buying Synergy CHC Corp. (NASDAQ:SNYR) Now?
Synergy CHC Corp. ( NASDAQ:SNYR ), is not the largest company out there, but it saw a decent share price growth of 18...Synergy CHC's (NASDAQ:SNYR) Problems Go Beyond Poor Profit
Synergy CHC Corp.'s ( NASDAQ:SNYR ) lackluster earnings announcement last week disappointed investors. We think that...Shareholder Returns
| SNYR | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -2.9% | -1.2% | -0.4% |
| 1Y | -93.7% | -17.3% | 18.4% |
Return vs Industry: SNYR underperformed the US Personal Products industry which returned -17.3% over the past year.
Return vs Market: SNYR underperformed the US Market which returned 18.4% over the past year.
Price Volatility
| SNYR volatility | |
|---|---|
| SNYR Average Weekly Movement | 13.7% |
| Personal Products Industry Average Movement | 8.4% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: SNYR's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: SNYR's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 28 | Jack Ross | synergychc.com |
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, Mexico, and internationally. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name. The company also provides hand care products under the Hand MD brand name; Neuragen a homeopathic product; and UrgentRx, an over the counter drug.
Synergy CHC Corp. Fundamentals Summary
| SNYR fundamental statistics | |
|---|---|
| Market cap | US$2.92m |
| Earnings (TTM) | -US$15.79m |
| Revenue (TTM) | US$27.70m |
Is SNYR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SNYR income statement (TTM) | |
|---|---|
| Revenue | US$27.70m |
| Cost of Revenue | US$9.59m |
| Gross Profit | US$18.11m |
| Other Expenses | US$33.90m |
| Earnings | -US$15.79m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.06 |
| Gross Margin | 65.37% |
| Net Profit Margin | -56.98% |
| Debt/Equity Ratio | -109.2% |
How did SNYR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/09 21:46 |
| End of Day Share Price | 2026/07/09 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Synergy CHC Corp. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Edward Woo | Ascendiant Capital Markets LLC |
| Sean McGowan | Roth Capital Partners |